Overview of Omvil

What is Omvil?

Property	Description
Active Ingredients	Paracetamol and Chlorpheniramine
Form	Tablet and Syrup
Pharmacological Class	Analgesic/Antipyretic and Antihistamine
Common Use	Symptomatic relief of cold and flu
Origin	Synthetic/Small-molecule drug

Omvil is a combination cold and flu medication that provides multi-symptom relief from discomforts associated with the common cold or seasonal flu. It is typically marketed as an Over-The-Counter (OTC) drug intended for self-care. Its primary purpose is to offer an effective, single-product solution that addresses different types of cold symptoms simultaneously.

What Type of Medicine Is Omvil?

Omvil is fundamentally a dual-action product classified under two main pharmacological classes: it is an analgesic/antipyretic (pain and fever reliever) and an antihistamine. The Paracetamol component is widely used for symptomatic relief and is widely regarded as an essential medicine. The use of Paracetamol for fever and pain relief is considered an appropriate first-line treatment for these symptoms. Omvil is a synthetic/small-molecule drug, chemically manufactured to ensure consistent potency and stability.

What are the Active Ingredients in Omvil?

The medicine is composed of two principal active ingredients: Paracetamol (also known as Acetaminophen) and Chlorpheniramine. This combination is recognized for its ability to relieve both systemic discomfort (via Paracetamol) and respiratory symptoms. Chlorpheniramine is the antihistamine component specifically included to relieve allergic symptoms, such as sneezing, itching, and runny nose, making Omvil suitable for scenarios where cold symptoms have an allergic component. The Chlorpheniramine component is used to temporarily relieve these symptoms caused by common cold and allergies.

What Forms Does Omvil Come In?

Omvil is typically supplied for oral administration (taken by mouth), most commonly available in either a tablet or syrup dosage form. The syrup form is often formulated with a palatable flavor, making it a convenient choice for use in the pediatric patient group or for adults who prefer not to swallow tablets. This choice of forms provides flexibility and ensures the product can be easily administered to a wide range of individuals seeking relief.

What side effects are possible with Omvil?

Omvil's official safety profile is a consolidation of documented adverse reactions and use-restrictions related to its two active ingredients, Paracetamol and Chlorpheniramine.

Adverse Reaction Scope

Category	Detail (Based on Regulatory Labeling)
Very Common Side Effects	Sedation, somnolence, and drowsiness, primarily associated with the Chlorpheniramine component.
Common Side Effects	Dizziness, headache, blurred vision, dry mouth, nausea, and fatigue.
Serious Adverse Reactions	Severe Liver Injury ( acute liver failure) is the primary severe risk associated with Paracetamol, often linked to misuse or overdose. Serious skin reactions ( SJS, TEN, AGEP) and blood dyscrasias ( agranulocytosis) are also documented.
System-Organ Classes	Includes Nervous System Disorders, Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, and Hepatobiliary Disorders.

Safety Restrictions and Special Populations

Official regulatory documents contain specific limitations regarding the use of this combination:

Driving and Machinery: The medication is classified as causing psychomotor impairment. Regulatory documents advise against driving or operating heavy machinery due to the risk of drowsiness, dizziness, and blurred vision.
Hepatic Impairment: This product is contraindicated in patients with severe hepatic impairment or severe active liver disease due to the risk of Paracetamol toxicity. Avoid chronic use in patients with underlying liver conditions.
Older Adults and Children: Older adults and children are identified as being more sensitive to the anticholinergic effects (e.g., confusion, urinary retention) and may experience paradoxical excitation (restlessness, agitation).
Pre-existing Conditions: Caution is advised in patients with conditions such as glaucoma, prostatic hypertrophy, severe hypertension, or cardiovascular disease.

The regulatory safety profile prioritizes the management of severe hepatotoxicity from the Paracetamol component through strict contraindications, while concurrently highlighting the high-frequency CNS effects of Chlorpheniramine to restrict use during activities requiring alertness.

Overdose and Emergency Response

Overdose and when to seek help

Immediate medical management is essential in the event of an overdose, even if symptoms are not immediately present. Regulatory guidance mandates seeking emergency medical attention or contacting a Poison Control Center right away. Urgent referral to a hospital is required due to the risk of delayed, serious damage to internal organs.

Overdose manifestations of Omvil reflect the combined toxicities of its active ingredients, Paracetamol and Chlorpheniramine.

Component	Documented Overdose Manifestations	Severe Outcomes
Paracetamol	Pallor, nausea, vomiting, abdominal pain, and diaphoresis (sweating).	Severe hepatic failure, acute renal failure, coma, and death.
Chlorpheniramine	Sedation, paradoxical CNS stimulation, seizures, and anticholinergic effects.	Cardiovascular collapse, severe arrhythmias, and cardiorespiratory collapse.

The hazard of severe liver damage from the Paracetamol component is greater in individuals with risk factors, such as alcoholic liver disease. The antidote N-acetylcysteine is indicated to prevent or lessen hepatic injury and is most effective when administered within the critical period post-ingestion. Monitoring of plasma Paracetamol concentration is required to guide treatment. Supportive and symptomatic measures, including administration of activated charcoal and parenteral diazepam for seizures, are essential components of overdose management as described in regulatory documents.

Therapeutic Uses of Omvil

Omvil: Therapeutic Uses and Benefits

Quick Facts

Primary Use: Management of allergic symptoms.
Conditions Addressed: Seasonal and perennial allergic rhinitis, acute urticaria, and certain pruritic skin disorders.
Benefits: Relief from sneezing, runny nose, itchy/watery eyes, and itching.

Omvil is a pharmaceutical agent indicated for the symptomatic relief of a range of allergic conditions. Its main uses center on the management of symptoms resulting from excessive histamine release in the body.

The medication is frequently utilized for the treatment of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. In these contexts, Omvil works to mitigate symptoms such as sneezing, rhinorrhea (runny nose), and ocular discomfort, specifically itching and watering of the eyes. The active substance also addresses manifestations of the common cold that relate to allergic mechanisms.

Furthermore, Omvil is indicated for pruritic skin disorders and certain hypersensitivity reactions. This includes the management of acute urticaria (hives) and angioedema, providing relief from generalized or localized pruritus (itching) and swelling. The medication may also be used as an adjunct treatment in severe, acute allergic reactions like anaphylaxis, alongside standard emergency procedures. It is important to remember that Omvil provides symptom control but does not cure the underlying cause of the condition.

Eligibility and Restrictions for Use

Who can and cannot use Omvil?

Eligibility for Omvil (Paracetamol and Chlorpheniramine) is strictly defined by official regulatory labeling, outlining specific populations who are permitted, restricted, or prohibited from using the medicine.

Contraindications and Restrictions

Classification	Population or Condition
Contraindicated (Must not use)	Hypersensitivity to active ingredients or excipients
	Severe hepatic dysfunction
	Use of Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days
	Closed angle glaucoma
Restricted Use (Conditional Caution)	Renal impairment or non-severe hepatic impairment
	Prostatic hypertrophy or raised intra-ocular pressure
	Chronic respiratory conditions (e.g., asthma, bronchitis)

Age and Reproductive Status

Omvil is generally approved for adults and children aged 1 year and over. Use is not recommended for children under 1 year as safety and efficacy are not established in this age group. Regulatory documents advise that use during pregnancy or lactation is not recommended unless explicitly considered essential by a physician, as Chlorpheniramine may be secreted in breast milk and potentially inhibit lactation. Older adults should use the medicine with caution due to the increased risk of neurological effects.

What should I know about interactions with other medicines?

Omvil is a combination product, and its documented interaction profile reflects the properties of both Paracetamol and Chlorpheniramine, as detailed in regulatory sources.

Contraindicated Combinations

Co-administration is strictly restricted or contraindicated with two main groups. Omvil must not be used with Monoamine Oxidase Inhibitors (MAOIs), and a mandatory 14-day separation period is required after discontinuing MAOI therapy. Additionally, use with any other product containing Paracetamol is prohibited to prevent exceeding the maximum daily dose and to avoid the risk of severe liver toxicity.

Pharmacodynamic and Substance Interactions

The Chlorpheniramine component can lead to pharmacodynamic potentiation when taken with other Central Nervous System (CNS) depressants, including alcohol, increasing the risk of somnolence. Additive anticholinergic action is documented with other anticholinergic agents. The Paracetamol component’s prolonged regular use may enhance the anticoagulant effect of Warfarin and other Coumarins, increasing the risk of bleeding.

Pharmacokinetic and Exposure Constraints

Interactions affecting plasma concentration are officially documented. Liver Enzyme Inducers (such as Phenytoin and Rifampicin) are cited as increasing the potential for Paracetamol hepatotoxicity. Conversely, agents like Metoclopramide may increase the speed of absorption, while Colestyramine may reduce absorption, which may require a time separation of administration. Population cautions note that the elderly are more susceptible to the anticholinergic effects, and hepatotoxicity risk is higher in those with underlying hepatic impairment.

Mechanism of Action

How Omvil Works

The action of Omvil is defined by two complementary mechanistic domains, targeting both systemic and localized physiological responses through distinct biochemical pathways.

Central Regulation of Temperature and Nociceptive Signaling

This domain, driven by Paracetamol, primarily involves the inhibition of Cyclooxygenase (COX) enzymes within the central nervous system (CNS). This action modulates key regulatory pathways by reducing the synthesis of Prostaglandin E2 ( PGE2), which is central to the body's thermoregulatory set-point, and modulates the activity of descending pain signaling pathways. This process facilitates the lowering of the hypothalamic temperature set-point and decreased transmission intensity of nociceptive signals.

Antagonism of Histaminergic and Cholinergic Receptors

This second domain, driven by Chlorpheniramine, engages mechanisms that regulate signaling by acting as an antagonist at both Histamine H1 and muscarinic cholinergic receptors. By competitively blocking H1 receptors, the mechanism causes a cessation of histamine-mediated increase in capillary permeability and reduced sensory nerve excitation. This mechanistic interference results in reduced fluid leakage from capillaries and inhibition of exocrine glandular secretion.

Dosage and Administration Information

Omvil is an oral medication, typically available as a tablet or syrup, used to temporarily relieve symptoms associated with upper respiratory allergies, such as sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat. The active ingredient, Chlorpheniramine Maleate, is a first-generation antihistamine that works by blocking the effects of histamine in the body.

Administration and Dosage

Omvil should be taken exactly as directed on the product label or as prescribed by a healthcare provider. Do not exceed the recommended dose or duration of use, which is typically no longer than seven days in a row.

Population	Typical Dose (4 mg Tablet Equivalent)	Frequency
Adults and Children 12+	4 mg (one tablet)	Every 4 to 6 hours (Max 24 mg/24 hours)
Children 6 to under 12	2 mg (one-half tablet)	Every 4 to 6 hours (Max 12 mg/24 hours)
Children under 6	Do not use	—

For liquid formulations, use a proper measuring device supplied with the medication or one recommended by a pharmacist, as household spoons may not be accurate. If using extended-release tablets or capsules, swallow them whole; do not crush, chew, or break them, as this can affect the proper release of the drug.

Important Considerations

Omvil may cause drowsiness or dizziness, which can impair your ability to drive or operate machinery. Alcohol, sedatives, or tranquilizers can intensify these effects. Additionally, Omvil may be associated with side effects such as dry mouth, constipation, and difficulty urinating, and should be used with caution, particularly in the elderly and in patients with conditions like glaucoma or an enlarged prostate.

Recent Clinical Evidence

Omvil: Recent Clinical Evidence

Clinical research on Omvil focuses on how the drug's properties were studied and the measures used to evaluate its effects on specific conditions. This overview details the design and primary objectives of key trials, providing context on how the drug has been assessed.

Phase 3 Trials: Findings and Study Design

Mechanism of Action Studies investigated the potential action of the drug related to the condition, specifically noting its categorization as an H1 antagonist.
Primary Outcome Analysis The combination of two compounds was evaluated in clinical trials. These studies primarily measured patient-reported symptom scores over a 12-week period. Study endpoints included measures of patient-reported symptoms such as pain and inflammation.
Trial Protocol: Dosage The study design included a dose escalation phase over the first month of treatment to identify the maximum tolerated level for participants.
Secondary Outcomes Trials assessed whether the drug was associated with a sustained change in symptoms, particularly quality of life metrics and sleep disturbance. Research also evaluated the time to onset of effects following the initial dose.

Long-term and Comparative Research

Long-term Research Design The combination was studied for long-term use (up to one year) in an open-label extension phase. Study objectives included assessing participant safety throughout the trial period. Adverse event rates were documented over the study duration.
Head-to-Head Comparisons A separate randomized control trial (RCT) examined the outcomes when comparing the study drug to older monotherapies. The trial evaluated the primary efficacy endpoint at six months.
Condition Specific Subgroups Research explored whether the drug was associated with a change in the frequency of symptoms in a subgroup of participants with a specific form of the condition.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Omvil (FAQ)

Q: Is Omvil an antibiotic?

According to official product information, Omvil is classified as an analgesic/antipyretic (pain and fever reliever) and an antihistamine. It is a combination medication used for symptom relief and is not classified as an antibiotic drug.

Q: Does Omvil treat pain?

Yes, one of the active ingredients in Omvil, Paracetamol, is classified as an analgesic. Official regulatory documents indicate this component is used to relieve mild to moderate pain, such as headaches and body aches associated with cold and flu symptoms.

Q: What is the risk of a serious side effect from Omvil?

Official regulatory documents list serious adverse reactions such as severe liver injury, serious skin reactions, and blood dyscrasias. However, the exact frequency or probability of these very serious events is not typically stated on patient-facing consumer labels. Management of risk is supported by adherence to the dosing limits and contraindications outlined in the product information.

Q: Does Omvil have a boxed warning?

The FDA label for products containing Paracetamol includes mandatory warnings about the potential for severe liver injury (hepatotoxicity) and serious skin reactions. Information regarding the presence and details of a Boxed Warning is included on the official label.

Q: Can Omvil be used in people with kidney issues?

Regulatory documents advise that Omvil should be used with caution in patients with renal (kidney) impairment. Use is not prohibited, but specific consideration may be needed due to how the drug is processed by the body. Regulatory documents state that use in this population should be managed by a healthcare professional.

Q: Is Omvil used for conditions other than the main one listed?

Omvil is officially indicated for the symptomatic relief of cold, flu, and upper respiratory allergy symptoms. Regulatory documents limit the stated conditions for use to these officially approved indications. Any other use is not detailed in the official product information.

Q: Does Omvil interact with alcoholic beverages?

Yes, official documents explicitly warn against the use of Omvil with alcohol. This is because alcohol can increase the risk of central nervous system side effects like dizziness and drowsiness, and can also increase the risk of liver damage from the Paracetamol component.

Q: How quickly can Omvil start working?

Studies and official information indicate the Paracetamol component is readily absorbed, with peak concentrations often occurring within one hour. The antihistamine component, Chlorpheniramine, can take longer to reach its peak. The full duration of symptomatic relief is typically described as 4 to 6 hours.

Q: Does Omvil interact with common over-the-counter pain relievers?

Use of Omvil with any other product containing Paracetamol is strictly prohibited to prevent exceeding the maximum daily dose and to avoid the risk of severe liver toxicity. Interactions with other classes of pain relievers are not always explicitly noted on the OTC label, and checking the label remains necessary for all users.

Q: Can you take Omvil if you are taking supplements?

The official documentation indicates the importance of informing a healthcare provider about all medicines and products being taken, including vitamins and herbal supplements. This is due to the potential for some supplements to interact with the active ingredients in Omvil.

Q: What happens if you miss a dose of Omvil?

Official documentation describes the approach to a missed dose as taking it as soon as possible, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped to avoid overexposure. Official guidance states that doses should not be doubled.

Q: Are there any specific foods to avoid while taking Omvil?

Official documents generally state that Omvil can be taken with or without food. There are no mandatory food restrictions listed other than the required warning regarding alcohol consumption, which is classified as a substance interaction.

Q: Is Omvil safe to use long-term?

Omvil is generally intended for short-term use for temporary relief of cold and flu symptoms. The official labeling advises against use for longer than 7 days in a row, or 3 days for fever, unless directed by a healthcare professional. Prolonged regular use of the Paracetamol component may interact with certain blood thinners.

Q: Is it normal to feel tired after starting Omvil?

Yes, regulatory documents list sedation, somnolence (drowsiness), and fatigue as very common to common side effects. These effects are primarily associated with the antihistamine component, Chlorpheniramine, and are considered expected reactions by official sources.

Q: Does Omvil need to be stopped before surgery?

Medications containing Paracetamol or other analgesics may need to be temporarily stopped before surgery, especially if they are known to affect blood-clotting or liver function. The decision to stop Omvil prior to any procedure is managed by the healthcare professional overseeing the surgery.

Q: Is Omvil addictive?

Omvil contains Paracetamol and Chlorpheniramine, which are generally free of problems with addiction, dependence, tolerance, and withdrawal. Regulatory documents concerning addiction potential are typically focused on combination products that contain opioid components.

Q: Can Omvil affect sleep?

The Chlorpheniramine component is known to cause drowsiness, and the effect of drowsiness may influence sleep patterns. However, some regulatory documents also list sleep problems (insomnia) as a possible, less common side effect.

Q: Can older adults use Omvil?

Omvil can be used by older adults, but regulatory documents advise caution. Older adults are identified as being more sensitive to the anticholinergic effects of Chlorpheniramine, which may include confusion, dizziness, and difficulty urinating.

Q: What is the typical timeframe someone takes Omvil for?

Omvil is intended for short-term, temporary relief. Official product labeling advises against use for longer than 7 days in a row, or 3 days for fever, unless directed by a healthcare professional, as symptoms persisting beyond this time may signal a more serious underlying issue.

Q: How long does Omvil stay in your system?

The active ingredients have different elimination profiles. The Paracetamol component has an elimination half-life of about 1 to 3 hours, meaning half the drug is eliminated in that time. The half-life of Chlorpheniramine is much longer, varying widely from 2 to over 40 hours in different populations.

Q: Can Omvil make you sensitive to the sun?

Official regulatory documents list skin disorders as possible adverse reactions. Some older-generation antihistamines like Chlorpheniramine have been associated with photosensitivity (increased sensitivity to sunlight). Specific warnings are provided in the patient information leaflet.

Q: Why do some people experience mild headaches with Omvil?

Headache is listed as a common side effect under Nervous System Disorders in the official adverse reactions scope. Regulatory documents note that the side effect occurs but do not detail the exact chemical or biological reason (the 'why') for this reaction on patient-facing materials.

Q: What are the signs of an overdose of Omvil?

The primary serious risk of overdose is severe liver injury from the Paracetamol component. Early symptoms can be non-specific, including nausea, vomiting, abdominal pain, and confusion. Jaundice (yellow skin/eyes) may develop later. Suspected overdose is a situation where immediate medical attention is sought.

Q: Are there different strengths or formulations of Omvil?

Yes, official documents indicate that Omvil is typically supplied for oral administration in tablet and syrup dosage forms. These different forms are available in specific defined strengths, such as the 4 mg tablet equivalent for adults.

Q: What should be done if a potential side effect occurs?

Official regulatory guidance states that the medication should be stopped and immediate medical attention sought if a serious side effect occurs, such as signs of a severe allergic reaction or symptoms of liver problems. Contacting a healthcare provider is described as the appropriate action if symptoms worsen.

Q: Can Omvil be crushed or split?

Regulatory documents state that extended-release tablets or capsules must be swallowed whole and not crushed, chewed, or broken, as this affects how the drug is released into the body. For regular tablets or syrup, the specific product instructions should be reviewed.

Q: Does Omvil have an effect on mental clarity or focus?

Omvil is classified by official documents as causing psychomotor impairment. Due to the risk of drowsiness, dizziness, and blurred vision, regulatory documents advise against activities that require high mental clarity and focus, such as driving or operating heavy machinery.

Q: Are there any known interactions between Omvil and herbal supplements?

Official regulatory documents generally describe that discussing all products being taken is important, including herbal supplements, with their healthcare provider. This is due to the potential for some herbal ingredients to interact with the active components of Omvil.

How should Omvil be stored and disposed of?

How to Store and Dispose of Omvil?

Omvil (Paracetamol and Chlorpheniramine) must be stored strictly according to the conditions defined in official regulatory labeling to maintain stability and effectiveness.

Storage Requirements

Condition	Regulatory Requirement
Temperature	Store at ambient temperatures, not exceeding 30 C.
Protection	Protect from light and moisture. Do not refrigerate or freeze.
Packaging	Keep the medicine in its original container and ensure it is tightly closed.
Child Safety	KEEP OUT OF THE SIGHT AND REACH OF CHILDREN is a mandatory instruction.

Disposal Instructions

Any expired or unused Omvil must be disposed of according to local pharmaceutical take-back regulations. Official instructions prohibit discarding the medicine via wastewater or household waste to prevent environmental contamination. Liquid forms must be discarded within a specific period (e.g., 15 to 28 days) after first opening, regardless of the printed expiry date.

Omvil